One of the biggest challenges in immunotherapy area is to find accurately which patients will benefit from a therapy or a combination of therapies. To help drug developers getting this information, the assessment of biomarkers through clinical research studies represent a key step.

HalioDx arranges a Medicon Valley Alliance morning meeting, and Vibeke Sundvold Gjerstad (Translational Scientist in Lytix Biopharma) is invited as a speaker.

Medicon Valley Alliance is a Danish-Swedish networking organization for the entire life science community in Greater Copenhagen.

For more information